(Total Views: 1264)
Posted On: 05/25/2017 9:28:21 AM
Post# of 3

$AVGR Hold for VISION study for the Company’s Lumivascular technology, New Cardiovascular Horizons (NCVH) annual conference on May 31, 2017
http://investors.avinger.com/phoenix.zhtml?c=...ID=2276569
http://investors.avinger.com/phoenix.zhtml?c=...ID=2276569

